Insider · CIK 0001174475
BROWN MICHAEL S
Reports to the SEC for 2 companies · TARRYTOWN, NY
Transactions
50
Companies
2
Filings
8
CIK
0001174475
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-01-02 | REGNREGENERON PHARMACEUTICALS, INC.A Award | — |
| 2026-01-02 | REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2025-01-02 | REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2025-01-02 | REGNREGENERON PHARMACEUTICALS, INC.A Award | — |
| 2024-06-14 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$1.6M |
| 2024-06-14 | REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion | +$960K |
| 2024-06-14 | REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-05-28 | REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion | +$733K |
| 2024-05-28 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$1.14M |
| 2024-05-28 | REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-01-02 | REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2024-01-02 | REGNREGENERON PHARMACEUTICALS, INC.A Award | — |
| 2023-12-27 | REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion | +$989K |
| 2023-12-27 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$1.84M |
| 2023-12-27 | REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2023-04-21 | REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2023-04-21 | REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion | +$1.6M |
| 2023-04-21 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$2.45M |
| 2023-02-06 | REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion | +$1.6M |
| 2023-02-06 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$399K |
| 2023-02-06 | REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2023-02-06 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$2.45M |
| 2023-01-27 | REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2023-01-27 | REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion | +$520.01 |
| 2023-01-27 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$747 |
| 2023-01-06 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$2.29M |
| 2023-01-06 | REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2023-01-06 | REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion | +$1.6M |
| 2023-01-03 | REGNREGENERON PHARMACEUTICALS, INC.A Award | — |
| 2023-01-03 | REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$1.32M |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion | +$755K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$94.7K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$154K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$153K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$226K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$154K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$374K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$154K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$152K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$76.2K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$153K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$153K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion | +$909K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$151K |
| 2022-11-08 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$76.5K |
| 2022-03-30 | REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion | +$153K |
| 2022-03-30 | REGNREGENERON PHARMACEUTICALS, INC.S Sale | −$285K |
Recent filings
- 4BROWN MICHAEL S0001174475-26-000002SEC(opens sec.gov)
- 4BROWN MICHAEL S0001968202-25-000003SEC(opens sec.gov)
- 4BROWN MICHAEL S0001968202-24-000102SEC(opens sec.gov)
- 4BROWN MICHAEL S0001104659-24-066045SEC(opens sec.gov)
- 4BROWN MICHAEL S0001968202-24-000022SEC(opens sec.gov)
- 4BROWN MICHAEL S0001883850-23-000109SEC(opens sec.gov)
- 4BROWN MICHAEL S0001968202-23-000009SEC(opens sec.gov)
- 4BROWN MICHAEL S0001883850-23-000045SEC(opens sec.gov)
Companies
Address
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY, 10591